Real World Evidence (RWE) to Enhance Value-Based Market Access of the PCSK9 Inihibitors in Italy- Treatment Patterns and Cv-Related Hospitalizations Among High Risk Hefh and Secondary Prevention Patients in Three Real-World Data Systems
Abstract
Authors
E Pessina L Degli Esposti F Lapi AP Maggioni C Uslenghi